CRMD CorMedix Inc
P/E
3.618
Forward P/E
15.13
Price/Sales
1.514
Beta
1.471
Div Yield
--
Market Cap
--
Company Analysis
Latest News
🔴 CRMD is trading 6% down today after shareholders reject key governance proposals
CRMD is trading 6% down at $7.92 after investors reacted to significant governance setbacks during the company's June 23, 2026 annual meeting. • Shareholders...
CorMedix Shareholders Reject Five Key Governance and Charter Amendment Proposals
CorMedix Inc. announced the results of its 2026 Annual Meeting of Stockholders held on June 23, 2026. While shareholders approved routine proposals, including...
CorMedix Revenue Surges 384%, Driven by DefenCath Market Demand
CorMedix Inc. (CRMD) reported 384.60% year-over-year revenue growth on June 17, 2026. This performance distinguishes the company among its small-cap healthcare...